Emergent BioSolutions Inc. — Director's Dealing 2021

Feb 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-02-24

Reporting Person: El-Hibri Fuad (Director, Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-24	Employee Stock Options (Right to Buy)	$93.49	A	27808	Acquired	2031-02-23	Common Stock (27808)	Direct
2021-02-24	Restricted Stock Unit	$	A	13906	Acquired		Common Stock (13906)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On February 24, 2021, Mr. El-Hibri was granted 27,808 stock options vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date.

F3: On February 24, 2021, Mr. El-Hibri was granted 13,906 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date.